About ProtLLM Inc.

Designing the Future of Antibody Discovery

PROTLLM Inc. is a biotech startup pioneering a next-generation AI/ML driven antibody discovery platform.

By harnessing advanced machine learning models, we can unlock the therapeutic potential of previously "undruggable" targets in oncology, neurology, and autoimmune diseases.

Our platform in development integrates closed-loop design, IP-cleared innovation, and predictive modeling to accelerate the development of novel biologics that traditional methods have failed to deliver.

What We’re Building

An end-to-end antibody discovery service platform that combines cutting-edge AI/ML algorithms with comprehensive wet lab validation to identify, optimize, and verify antibody clones with superior binding characteristics and developability profiles.